U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C7H17NO5
Molecular Weight 195.2136
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEGLUMINE

SMILES

CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

InChI

InChIKey=MBBZMMPHUWSWHV-BDVNFPICSA-N
InChI=1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1

HIDE SMILES / InChI

Molecular Formula C7H17NO5
Molecular Weight 195.2136
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Meglumine (N-methyl-D-glucamine) is a poorly metabolized derivative of sorbitol that has regulatory acceptance as a benign excipient for drug formulation to increase aqueous solubility of lipophilic drugs and improve their absorption. In conjugated form meglumine is used as a contrast agent.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
ISOPAQUE 280

Approved Use

Unknown

Launch Date

1974
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
A lithium-induced conformational change in serotonin transporter alters cocaine binding, ion conductance, and reactivity of Cys-109.
2001 Aug 17
Agonist-stimulated calcium decreases in ovine ciliated airway epithelial cells: role of mitochondria.
2001 Feb 15
Inwardly rectifying K(+) channels in spermatogenic cells: functional expression and implication in sperm capacitation.
2001 Jun 1
[Infiltrated cutaneous leishmaniasis and sporotrichosis caused by Leishmania major. First Senegalese case].
2001 Mar
Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis.
2001 Mar-Apr
Mechanism underlying slow kinetics of the OFF gating current in Shaker potassium channel.
2001 May
Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100 (platelet function analyzer).
2001 May
Two open states and rate-limiting gating steps revealed by intracellular Na+ block of human KCNQ1 and KCNQ1/KCNE1 K+ channels.
2001 May 15
Choline blocks AMPA-induced dark cell degeneration of Purkinje neurons: potential role of the alpha7 nicotinic receptor.
2001 May 18
In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain.
2001 May 25
Background osmolyte current involved in cell volume regulation of neuroblastoma x glioma hybrid NG108-15 cells.
2001 Sep
Visceral leishmaniasis with pericarditis in an HIV-infected patient.
2002
Gender differences in vascular smooth muscle reactivity to increases in extracellular sodium salt.
2002 Feb
Dual effect of blocking agents on Ca2+-activated Cl(-) currents in rabbit pulmonary artery smooth muscle cells.
2002 Feb 15
Cytostatic potential of novel agents that inhibit the regulation of intracellular pH.
2002 Jul 15
Evaluation of a rapid immunochromatographic test for serodiagnosis of visceral leishmaniasis.
2002 Jun
Phospholipase C-mediated signalling is not required for histamine-induced catecholamine secretion from bovine chromaffin cells.
2002 Jun
Dehydroascorbic acid uptake by coronary artery smooth muscle: effect of intracellular acidification.
2002 Mar 1
[Cutaneous leishmaniasis of the lid].
2002 May
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Intravenous
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:25:47 GMT 2025
Edited
by admin
on Mon Mar 31 18:25:47 GMT 2025
Record UNII
6HG8UB2MUY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METHYLGLUCAMINE
INCI  
INCI  
Preferred Name English
MEGLUMINE
EP   II   INN   MART.   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INN  
Official Name English
1-DEOXY-1-(METHYLAMINO)-D-GLUCITOL
Common Name English
MEGLUMINE [ORANGE BOOK]
Common Name English
MEGLUMINE [II]
Common Name English
D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)-
Common Name English
D(-)-N-METHYLGLUCAMINE
Brand Name English
Meglumine [WHO-DD]
Common Name English
MEGLUMINE [EP MONOGRAPH]
Common Name English
NSC-52907
Code English
MEGLUMINE [JAN]
Common Name English
MEGLUMINE [USP-RS]
Common Name English
N-METHYLSORBITYLAMINE
Common Name English
MEGLUMINE [VANDF]
Common Name English
MEGLUMINUM [WHO-IP LATIN]
Common Name English
meglumine [INN]
Common Name English
MEGLUMINE [WHO-IP]
Common Name English
N-METHYLGLUCAMINE [MI]
Common Name English
MEGLUMINE [MART.]
Common Name English
MEGLUMINE [USP MONOGRAPH]
Common Name English
NSC-7391
Code English
Classification Tree Code System Code
NCI_THESAURUS C390
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
228-506-9
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
NCI_THESAURUS
C61828
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
SMS_ID
100000081443
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
DAILYMED
6HG8UB2MUY
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
EPA CompTox
DTXSID0023244
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
EVMPD
SUB08715MIG
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
FDA UNII
6HG8UB2MUY
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
WIKIPEDIA
MEGLUMINE
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
CAS
6284-40-8
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
MESH
D008536
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
DRUG CENTRAL
5194
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
NSC
7391
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
NSC
52907
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
ChEMBL
CHEMBL1200570
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
INN
4205
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
RS_ITEM_NUM
1379140
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
RXCUI
6704
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY RxNorm
PUBCHEM
8567
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
MEGLUMINE
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY Description: A white or almost white, crystalline powder; odourless or almost odourless. Solubility: Freely soluble in water; slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R.Category: Used in the preparation of meglumine amidotrizoate and meglumine iotroxate as radiocontrast media. Storage: Meglumine should be kept in a well-closed container.Requirements: Meglumine contains not less than 99.0% and not more than the equivalent of 100.5% of C7H17NO5, calculated with reference to the dried substance.
MERCK INDEX
m7420
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY Merck Index
CHEBI
59732
Created by admin on Mon Mar 31 18:25:47 GMT 2025 , Edited by admin on Mon Mar 31 18:25:47 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY